SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (41894)6/10/2003 12:54:37 PM
From: Frederick Langford  Respond to of 57110
 
ICOS Corp initiated with Overweight at Lehman; target $53 (ICOS) 39.27: Lehman initiates coverage of ICOS with an Overweight rating and $53 target based on an optimistic outlook for their erectile dysfunction drug Cialis (co-developed with LLY), which firm believes has a $1.7 bln peak sales potential.

Fred



To: Jorj X Mckie who wrote (41894)6/10/2003 1:39:06 PM
From: Frederick Langford  Read Replies (1) | Respond to of 57110
 
Looks like folks are finally realizing that the European VAT tax on internets will not be good for EBAY...

Fred


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News